Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if HIMS & HERS HEALTH INC (NYSE:HIMS) is suited for growth investing. Investors should of course do their own research, but we spotted HIMS & HERS HEALTH INC showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.
Key Considerations for Growth Investors.
HIMS exhibits a strong Return on Equity (ROE) of 29.93%, indicating the company's ability to generate solid returns on shareholder investments. This metric reflects the company's efficient utilization of equity capital and its profitability.
HIMS has a strong history of beating EPS estimates in the last 4 quarters, signaling its ability to consistently exceed market expectations. This indicates the company's strong financial performance and its potential for creating shareholder value.
With impressive 1-year revenue growth of 85.99%, HIMS showcases its ability to generate increased sales and revenue. This growth highlights the company's strong customer demand and its effective business strategies.
The quarter-to-quarter (Q2Q) revenue growth of 111.0% of HIMS has been strong, reflecting the company's ability to generate consistent sales growth. This growth suggests the company's ability to meet customer needs and drive revenue growth.
HIMS has experienced notable growth in its operating margin over the past year, reflecting improved operational performance. This growth suggests the company's ability to generate higher profits from its core business activities.
With positive growth in its free cash flow (FCF) over the past year, HIMS showcases its ability to generate strong cash flows and maintain a solid financial position. This growth reflects the company's efficient utilization of capital and its commitment to long-term value creation.
The EPS of HIMS has exhibited growth from one quarter to another (Q2Q), with a 300.0% increase. This underscores the company's ability to generate higher earnings and improve its financial standing.
The average next Quarter EPS Estimate for HIMS has experienced a 4.19% change in the last 3 months, reflecting evolving expectations by analysts regarding the company's EPS performance.
The 1-year EPS growth of HIMS (%EPSYGROWTHTTM%) highlights the company's ability to consistently improve its earnings performance and suggests a positive outlook for future profitability.
HIMS shows accelerating EPS growth: when comparing the current Q2Q growth of 300.0% to the previous year Q2Q growth of 200.0%, we see the growth rate improving.
How does the complete fundamental picture look for HIMS?
Every day, ChartMill assigns a Fundamental Rating to each stock, providing a score ranging from 0 to 10. This rating is determined by evaluating various fundamental indicators and properties.
We assign a fundamental rating of 6 out of 10 to HIMS. HIMS was compared to 102 industry peers in the Health Care Providers & Services industry. HIMS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. HIMS is valued quite expensively, but it does show have an excellent growth rating. These ratings could make HIMS a good candidate for growth investing.
This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
HIMS & HERS HEALTH (NYSE:HIMS) meets Minervini’s Trend Template with strong technicals and explosive earnings growth, making it a high-growth momentum candidate.